Trypanosomiasis, African: Clinical Trials

1 trial for Trypanosomiasis, African, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 terminated. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Terminated 1
Phase 31Terminated 1

Follow Trypanosomiasis, African: new trials by email Literature Review of Trypanosomiasis, African trials Research Report on Trypanosomiasis, African

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Eflornithine + Nifurtimox Late-Stage Human African Trypanosomiasis (HAT)in West Nile, Uganda
Eflornithine plus Nifurtimox combination therapy - Trypanosomiasis, African
Phase 2 / Phase 3TerminatedEpicentre312002-10-012007-06-21

Broader conditions

Euglenozoa Infections (1)  ·  Infections (1)  ·  Parasitic Diseases (1)  ·  Protozoan Infections (1)  ·  Trypanosomiasis (1)  ·  Vector Borne Diseases (1)

Interventions

Eflornithine (1)

Sponsors

Epicentre (1)

Countries

Uganda (1)

Top investigators

Gerardo Priotto, MD MPH (1)  ·  Patrice Piola, MD MSc (1)